StonvexLoading…
StonvexStonvexStonvexCore line items from BLNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $10.50M | $13.88M | $12.39M | $14.78M |
Operating Income | $-2.42M | $-6.65M | $-6.90M | $-8.19M |
Net Income | $-7.54M | $-16.27M | $-2.20M | $-9.86M |
EPS (Diluted) | $-70.42 | $-21.40 | $-0.35 | $-0.98 |
Total Assets | $17.48M | $21.48M | $33.56M | $31.73M |
Total Liabilities | $16.63M | $22.99M | $20.16M | $32.84M |
Cash & Equivalents | $306.00K | $723.00K | $3.28M | $836.00K |
Free Cash Flow OCF − CapEx | $-1.88M | $-3.37M | $-6.21M | $-3.53M |
Shares Outstanding | 170.60K | 809.96K | 14.79M | 10.38M |